Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MaxCyte (MXCT) Regulatory News

Date Source Headline
2nd Sep 2020 7:00 am RNS Notice of Half Year Results
18th Aug 2020 7:00 am RNS Expansion of CARMA’s Phase I Trial of MCY-M11
14th Aug 2020 7:00 am RNS Holding(s) in Company
16th Jul 2020 6:04 pm RNS Director Dealings and Issue of Equity
15th Jul 2020 7:00 am RNS Trading Update
8th Jul 2020 7:00 am RNS APEIRON Biologics Clinical and Commercial License
1st Jul 2020 7:00 am RNS Block Listing Return & TVR
2nd Jun 2020 5:54 pm RNS Holding(s) in Company
28th May 2020 3:34 pm RNS Holding(s) in Company
26th May 2020 5:49 pm RNS Holding(s) in Company
26th May 2020 4:22 pm RNS Holding(s) in Company
26th May 2020 3:45 pm RNS Holdings in Company
21st May 2020 1:50 pm RNS Result of Special Meeting and Issue of Equity
14th May 2020 7:00 am RNS Poster Presentation on MCY-M11 at ASCO 2020
7th May 2020 7:00 am RNS License Agreement with Caribou Biosciences
1st May 2020 7:00 am RNS Result of Offering
30th Apr 2020 5:39 pm RNS Proposed Offering to raise up to £25.1 million
21st Apr 2020 7:00 am RNS Final Results for Year Ended 31 December 2019
9th Apr 2020 7:00 am RNS Business Update Related to COVID-19 Pandemic
24th Mar 2020 7:00 am RNS License Agreement with Allogene Therapeutics
21st Feb 2020 7:00 am RNS Consolidation of Trading Lines
20th Feb 2020 6:18 pm RNS AIM Block Admission Return / Total Voting Rights
5th Feb 2020 7:00 am RNS MaxCyte to Present at BIO CEO & Investor Conf
24th Jan 2020 4:31 pm RNS Grant Of Options
22nd Jan 2020 5:15 pm RNS Holding(s) in Company
22nd Jan 2020 5:11 pm RNS Holding(s) in Company
22nd Jan 2020 5:08 pm RNS Holding(s) in Company
20th Jan 2020 7:00 am RNS Trading Update
19th Dec 2019 7:00 am RNS New Executive Vice President and Trial Update
16th Dec 2019 5:25 pm RNS Director/PCA transaction initial notification
4th Dec 2019 7:00 am RNS Agreement with KSQ Therapeutics
21st Nov 2019 7:00 am RNS Vor Biopharma Clinical and Commercial License
14th Nov 2019 7:00 am RNS Presentation at Jefferies Healthcare Conference
7th Nov 2019 7:00 am RNS MaxCyte to Present at BIO-Europe 2019
1st Nov 2019 1:04 pm RNS Result of AGM
24th Oct 2019 7:00 am RNS MaxCyte Advances Phase I Clinical Trial
23rd Oct 2019 7:01 am RNS Presentations at Cell & Gene Therapy Congress
8th Oct 2019 7:00 am RNS Notification of AGM and Audit Declaration
7th Oct 2019 7:00 am RNS Editas Clinical and Commercial License Agreement
30th Sep 2019 7:00 am RNS Updates on CARMA Platform at Upcoming Meetings
FTSE 100 Latest
Value8,774.69
Change-10.64